PK in Pts With HRPC & Skeletal Metastes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Prostatic Neoplasms

Interventions

DRUG

Radium-223 chloride (Xofigo®, BAY88-8223) injection

Sterile, clear and colourless aqueous solution of radium-223 chloride free of endotoxins, for intravenous administration

Trial Locations (1)

Sutton